GDNEF yields 245.70% · JNJ yields 2.13%● Live data
📍 GDNEF pulled ahead of the other in Year 1
Combined, GDNEF + JNJ cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of GDNEF + JNJ for your $10,000?
Golden Eagle Retail Group Limited, an investment holding company, engages in development and operation of lifestyle center and stylish department stores in the People's Republic of China. The company operates through three segments: Retail Operations; Property Development and Hotel Operations; and Other Operations. It also operates supermarkets and hotels. As of December 31, 2021, the company operated 31 self-owned stores with a total gross floor area of 2,529,930 square meters and a total operating area of 1,713,415 square meters; and 15 lifestyle centers with a total gross floor area of 1,971,090 square meters in the People's Republic of China. In addition, it engages in online trading activities; property holding; operation of aquariums; and trading of cosmetic products. Further, the company is involved in the property development and investment activities. Additionally, it offers communication and information services, as well as invests in education services. The company is headquartered in Nanjing, China. Golden Eagle Retail Group Limited is a subsidiary of Golden Eagle International Retail Group Limited.
Full GDNEF Calculator →Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide, but strategically separated its Consumer Health business into Kenvue Inc. in 2023 to focus on its higher-growth, innovation-driven segments; the former Consumer Health brands (including TYLENOL, LISTERINE, and BAND-AID) are now owned by Kenvue. The company's core focus is now split between its Innovative Medicine (formerly Pharmaceutical) segment, which offers prescription products for complex diseases such as rheumatoid arthritis, various cancers, HIV/AIDS, and neurodegenerative disorders; and its MedTech (Medical Devices) segment, which provides advanced technology solutions including electrophysiology products, neurovascular care products, orthopaedics (hips, knees, spine), advanced surgery solutions, and disposable contact lenses under the ACUVUE brand. Company's two remaining segments primarily serve hospitals, healthcare professionals, wholesalers, and retailers, continuing its mission of advancing human health since its founding in 1886 and its current basing in New Brunswick, New Jersey.
Full JNJ Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.